Kazakhstan’s Center for Expertise of Medicines joined IPRF and IGDRP

| By | Drug Quality Control, Kazakhstan, Regulatory

The meetings of the Management Committee of IPRF (International Pharmaceutical Regulators Forum) and the Steering Committee of IGDRP (International Generic Drug Regulators Programme) held on November 12-13 in Geneva approved the admission of the State Enterprise “National Center for Expertise of Medicinal Products, Medical Devices and Medical Equipment” of the Ministry of Health of the Republic of Kazakhstan to IPRF and IGDRP.

In addition, the meeting reviewed the reports presented by the regulatory authorities of IPRF and IGDRP members with information on significant updating of the national legislations. The Management Committee (MC) of IPRF and Steering Committee (SC) of IGDRP assessed the presented management models for their subsequent use in the regulatory cooperation area.

The discussions resulted in the decision to elaborate a document on consolidation of IPRF and IGDRP, including the development of the management structure and operational procedures, in particular, those related to future budgeting, and subsequent approval of the Implementation Plan and Consolidation Agreement.

All proposals for the consolidation of IPRF and IGDRP were submitted to the ICH Assembly for discussion and final decision.